Biosimilars

Valderilio Feijó Azevedo

ISBN 10: 1838819355 / ISBN 13: 9781838819354

Edité par Intechopen Jun 2022, 2022

A propos de cet article

This item is printed on demand - it takes 3-4 days longer - Neuware -Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics. This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It also addresses future trends in the biosimilars market. 106 pp. Englisch.

N° de réf. du vendeur 9781838819354

Détails bibliographiques

• Titre: Biosimilars
• Éditeur: Intechopen Jun 2022
• Date de parution: 2022
• Langue: anglais
• ISBN à 10 chiffres: 1838819355
• ISBN à 13 chiffres: 9781838819354
• Reliure: Buch
• État de l'article: Neu
• Dimensions: 266 L x 185 H x 12 P (en millimètres) 266 millimètres de largeur par 185 millimètres de hauteur par 12 millimètres de profondeur
• Poids: 452 grammes

A propos de ce titre

Synopsis

Introduced in the 1980s, biologic medications have since become important tools in modern medicine. However, biologics are expensive, greatly affecting the healthcare budgets of both underdeveloped and developed countries. Fortunately, biosimilars, which are highly similar, reverse-engineered versions of existing biological medicines and their active ingredients, are now available as more affordable options for patients treated with biologics. This book discusses biosimilars with chapters on clinical trials, regulation, pharmacovigilance, and the interchangeability of biosimilars with biologics. It also addresses future trends in the biosimilars market.